Maintenance of a reducing redox balance is a critical physiologic function of red cells (RBC) that can be perturbed in variety of RBC pathologies. Here we describe a new approach to evaluate in vivo RBC redox status using a redox sensitive GFP (roGFP2) sensor under control of a β-globin mini-promoter, directing expression specifically to erythroid cells. roGFP2
Abstract
Maintenance of a reducing redox balance is a critical physiologic function of red cells (RBC) that can be perturbed in variety of RBC pathologies. Here we describe a new approach to evaluate in vivo RBC redox status using a redox sensitive GFP (roGFP2) sensor under control of a β-globin mini-promoter, directing expression specifically to erythroid cells. roGFP2
expressing RBCs demonstrate ratiometric and reversible shifts in fluorescence upon exposure to oxidants and reductants. We demonstrate that roGFP2 expressing RBC can be used to monitor thiol redox status during in vitro phenylhydrazine treatment and over the course of in vivo RBC aging, where a shift to a more oxidized state is observed in older cells. Thus, roGFP2 transgenic mice are a new and versatile tool that can be used to probe how RBC redox status responds in the context of drug therapy, physiologic stressors and pathologic states.
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Introduction
Many approaches for evaluation of RBC redox status have been established, including direct evaluation of the glutathione redox pair (GSH/GSSG) 1 , and indirect approaches such as measuring rates of reactive oxygen (ROS) production using oxidation sensitive dyes 2 and measurement of protein oxidation 3 . While useful, these methods have specific limitations.
Measurement of the GSH/GSSG ratio is notoriously difficult because of oxidation of GSH during cell disruption and sample preparation 1,4 ; ROS sensitive dyes exhibit promiscuous reactivity with multiple radical species 5 ; protein oxidation reflects accumulated damage, not current redox status 6 . Importantly, none of these measurements is well suited for in vivo experimentation. Development of redox-sensitive green fluorescent protein variants (roGFP's)
provides a new option for measuring cellular redox status. [7] [8] [9] [10] [11] [12] roGFP2 has been engineered as a redox sensor by replacement of S147 and Q204 positions of EGFP with two cysteine residues.
These cysteines are either reduced or form an intra-molecular disulfide bond in equilibrium with local redox status. Rising levels of oxidized roGFP indicate a shift in cellular redox status that is monitored by following the ratio of GFP fluorescence emission following excitation at 405 versus 488 nm. [9] [10] [11] 13 Here, we show how roGFP2-expressing RBC in transgenic mice can be used to follow, in vitro and in vivo, important changes in RBC redox status.
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Materials and Methods

Generation of roGFP2 transgenic mice
roGFP2 was sub-cloned into a ß-globin minigene expression plasmid pµ'LCR-βpr-BglII-3'β (int2-enh), 14 and micro-injected into pronuclei of fertilized C57BL/6J mouse oocytes. The best transgenic founder animal expressed GFP in ~ 50% of peripheral RBC by FACS, and gave rise to progeny with the same expression pattern. 
Flow cytometry
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Measurement of redox changes during RBC aging
Mice were injected i.v. with 1 mg sulfo-NHS-Biotin (Pierce) in normal saline to label, in vivo, all RBC. 17, 18 5 µL blood samples were taken and analyzed by flow cytometry after staining with streptavidin Cy-Chrom TM (BD Pharmingen) for determination of cell age and roGFP2 ratio. All animal protocols were approved by the TSRI IACUC.
Statistical Analysis:
Data are presented as mean ± SEM, compared using unpaired student t-test (Calculation: PRISM.
(Graphpad Software)).
Results and discussion
In order to create a model system for assessment of the redox status of erythrocytes, we have developed and characterized a line of transgenic mice that express a redox GFP transgene driven by a ß-globin mini-promoter. 10, 14 In transgenic animals ~50% of peripheral RBCs express roGFP2 ( Figure 1A ). Expression of roGFP2 had no effect on RBC survival as the survival curves are identical for both the GFP positive and GFP negative RBC ( Figure 1B ) and agree with studies performed by our group using non-transgenic mice on the same strain (B6/J) background (data not shown). [17] [18] [19] We compared complete blood counts of transgenic and non-transgenic mice and found no significant differences in RBC indices, WBC parameters or platelet count (Table S1 ), indicating that expression of roGFP2 does not impact RBC survival or development.
We performed in vitro flow cytometry experiments using roGFP2-expressing RBCs to characterize the response and dynamic fluorescence range of the redox sensor. When transgenic RBCs are incubated with t-butyl hydroperoxide (tBOOH), fluorescence intensity excited at 405nm (emitted at 520nm) increases while fluorescence intensity excited at 488nm (emitted at 520nm) decreases ( Figure S1 ). This emission intensity ratio (R405/488) increases in a dosedependent manner, reaching a plateau value at 1.43±0.03 ( Figure 1C ). R405/488 decreases subtly but significantly from 0.36±0.03 to 0.34±0.03 when RBCs are incubated with 10mM DTT (data not shown). Kinetics and reversibility of redox changes in transgenic RBC were monitored by continuous flow cytometry ( Figure 1D ). Based upon titration experiments, we used treatment with 10mM DTT or 100µM tBOOH to represent maximally reduced and maximally oxidized states of the roGFP2 sensor. The degree of oxidation of roGFP2 (OxiD roGFP2 ) was calculated according to the measured ratio R405/488, and the fully reduced and oxidized 488nm fluorescence intensity values ( Figure 1E) . 9, 15, 16 Since the redox sensor is thermodynamically reversible in RBCs, the actual redox potential of roGFP2 in
RBCs can be estimated according to the degree of oxidization of roGFP2 and the known midpoint potential E' roGFP (-280mV) using the Nernst equation. 9, 13 The correlation between R405/488 and E roGFP2 is shown in Figure 1F . We used roGFP2 transgenic cells and mice to successfully monitor redox changes in vitro upon exposure to the pro-hemolytic compound phenylhydrazine (PHZ) and in vivo to monitor redox changes during the normal physiologic process of RBC aging. PHZ causes ROS production and oxidative damage in RBC. 20 In vitro incubation with PHZ resulted in a dose-dependent increase of R405/488 that was reversed by administration of 10mM DTT (Figure 2A, B) . We next probed for redox changes accompanying normal RBC aging using an in vivo biotin labeling method 17, 21 For personal use only. on October 31, 2017. by guest www.bloodjournal.org From ( Figure 2C ). R405/488 of the labeled cells (increasing in age) was followed over time and compared to that of unlabeled, GFP positive RBC in control mice. At early time points, R405/488 remains stable. By 14 days post-labeling, the ratio shifts indicating a more oxidized state, and with increasing age the ratio continues to rise ( Figure 2D ). The increase in R405/488 can be partially reversed by DTT (not shown). This provides direct evidence that changes in redox balance occur as a normal part of RBC aging, implying that oxidative damage over time contributes to RBC senescence.
22,23
Based on previous reports, roGFP2 predominantly equilibrates with GSH/GSSG rather than other cellular redox pairs, through an interaction that can be facilitated by glutaredoxins. 9, 15, 16, 24 The relationship of roGFP2 fluorescence and the degree of oxidation of glutathione (OxiD GSH ) in RBCs was examined ( Figure S2A ). If completely equilibrated, the E GSH should be equal to E roGFP2 . In fact, the calculated E roGFP2 is always much more negative than the E GSH ( Figure S2B ).
A possible reason for this discrepancy includes spuriously high measured GSSG concentration due to oxidation during cell disruption 1 .
To our knowledge, this is the first biosensor described for measuring real time redox status in RBC. We show that roGFP2 expressing RBCs, both in vitro and in vivo, can be used to monitor RBC redox status avoiding artifacts associated with cell disruption. There are limitations of the sensor, including lack of complete reversibility upon exposure to high concentration of oxidants, and following prolonged oxidant stress in vivo-indicating modifications to the sensor outside of the labile cysteine residues may occur. Future studies will attempt to identify the nature of modifications that leave the sensor stuck in the 'On' position. Despite these limits, roGFP2
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From transgenic animals make accessible a novel approach for probing and monitoring RBC redox changes in response to exogenous insults, genetic defects or physiological challenges, and will improve our understanding of the role of redox changes across many RBC pathologies.
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